This topic contains a solution. Click here to go to the answer

Author Question: If an ABA reversal design is not feasible in studying a particular phenomenon, such as severe ... (Read 62 times)

BRWH

  • Hero Member
  • *****
  • Posts: 553
If an ABA reversal design is not feasible in studying a particular phenomenon, such as severe self-injurious behavior, an acceptable alternative might be a
 
  A) within-subjects design.
  B) multivariate analysis.
  C) multiple assessment design.
  D) multiple baseline design.

Question 2

Why is a final A to B (i.e, back to the treatment) reversal sometimes carried out in reversal designs?
 
  A) To demonstrate loss of control.
  B) To reduce the number of participants needed.
  C) For ethical reasons.
  D) Both A and C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nothere

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

Answer: D

Answer to Question 2

Answer: C




BRWH

  • Member
  • Posts: 553
Reply 2 on: Aug 4, 2018
Wow, this really help


Dominic

  • Member
  • Posts: 328
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library